A rank-based approach to evaluate a surrogate marker in a small sample setting.

Area of Science:

• Biostatistics
• Hepatology
• Pediatric Clinical Trials

Background:

• Clinical studies often use costly, invasive outcomes for chronic diseases.
• Existing surrogate marker methods require large sample sizes or strict assumptions.
• Small sample sizes limit the evaluation of surrogate markers in clinical research.

Purpose of the Study:

• To develop a novel rank-based nonparametric approach for evaluating surrogate markers in small sample settings.
• To assess alanine aminotransferase (ALT) as a surrogate marker for NAFLD activity score in pediatric NAFLD patients.

Main Methods:

• Developed a novel rank-based nonparametric statistical method.
• Applied the method to a small clinical trial of children with nonalcoholic fatty liver disease (NAFLD).
• Evaluated change in blood ALT levels as a surrogate for change in NAFLD activity score (biopsy-based).

Main Results:

• The novel rank-based nonparametric method is suitable for small sample sizes.
• Demonstrated the application of the method in a pediatric NAFLD trial comparing Vitamin E and placebo.
• Provided a statistical framework to assess ALT as a surrogate marker for NAFLD progression.

Conclusions:

• The developed rank-based nonparametric approach effectively evaluates surrogate markers in small clinical studies.
• This method offers a viable alternative for surrogate marker assessment when large sample sizes are not feasible.
• Facilitates more efficient clinical trial design and analysis in chronic disease research, such as pediatric NAFLD.